328 related articles for article (PubMed ID: 23133550)
1. Geographical variations in sex ratio trends over time in multiple sclerosis.
Trojano M; Lucchese G; Graziano G; Taylor BV; Simpson S; Lepore V; Grand'maison F; Duquette P; Izquierdo G; Grammond P; Amato MP; Bergamaschi R; Giuliani G; Boz C; Hupperts R; Van Pesch V; Lechner-Scott J; Cristiano E; Fiol M; Oreja-Guevara C; Saladino ML; Verheul F; Slee M; Paolicelli D; Tortorella C; D'Onghia M; Iaffaldano P; Direnzo V; Butzkueven H;
PLoS One; 2012; 7(10):e48078. PubMed ID: 23133550
[TBL] [Abstract][Full Text] [Related]
2. Gender ratio trends over time in multiple sclerosis patients from Argentina.
Rojas JI; Patrucco L; MIguez J; Sinay V; Cassara FP; Cáceres F; Liguori NF; Saladino ML; Deri N; Jaacks G; Marcilla MP; Arrigoni MI; Correale J; Fiol M; Ysrraelit MC; Carrá A; Curbelo MC; Martinez A; Steinberg J; Bestoso S; Hryb JP; Di Pace JL; Perassolo MB; Contentti EC; Caride A; Lopez PA; Martinez C; Reich E; Giunta D; Cristiano E
J Clin Neurosci; 2017 Apr; 38():84-86. PubMed ID: 28087187
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study.
Miclea A; Salmen A; Zoehner G; Diem L; Kamm CP; Chaloulos-Iakovidis P; Miclea M; Briner M; Kilidireas K; Stefanis L; Chan A; Evangelopoulos ME; Hoepner R
CNS Neurosci Ther; 2019 Apr; 25(4):527-531. PubMed ID: 30411534
[TBL] [Abstract][Full Text] [Related]
4. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Sharmin S; Roos I; Simpson-Yap S; Malpas C; Sánchez MM; Ozakbas S; Horakova D; Havrdova EK; Patti F; Alroughani R; Izquierdo G; Eichau S; Boz C; Zakaria M; Onofrj M; Lugaresi A; Weinstock-Guttman B; Prat A; Girard M; Duquette P; Terzi M; Amato MP; Karabudak R; Grand'Maison F; Khoury SJ; Grammond P; Lechner-Scott J; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Turkoglu R; Altintas A; Maimone D; Kermode A; Shalaby N; Pesch VV; Butler E; Sidhom Y; Gouider R; Mrabet S; Gerlach O; Soysal A; Barnett M; Kuhle J; Hughes S; Sa MJ; Hodgkinson S; Oreja-Guevara C; Ampapa R; Petersen T; Ramo-Tello C; Spitaleri D; McCombe P; Taylor B; Prevost J; Foschi M; Slee M; McGuigan C; Laureys G; Hijfte LV; de Gans K; Solaro C; Oh J; Macdonell R; Aguera-Morales E; Singhal B; Gray O; Garber J; Wijmeersch BV; Simu M; Castillo-Triviño T; Sanchez-Menoyo JL; Khurana D; Al-Asmi A; Al-Harbi T; Deri N; Fragoso Y; Lalive PH; Sinnige LGF; Shaw C; Shuey N; Csepany T; Sempere AP; Moore F; Decoo D; Willekens B; Gobbi C; Massey J; Hardy T; Parratt J; Kalincik T
Brain; 2023 Nov; 146(11):4633-4644. PubMed ID: 37369086
[TBL] [Abstract][Full Text] [Related]
5. Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.
Kampman MT; Aarseth JH; Grytten N; Benjaminsen E; Celius EG; Dahl OP; Holmøy T; Løken-Amsrud K; Midgard R; Myhr KM; Risberg G; Vatne A; Torkildsen O
J Neurol; 2013 Jun; 260(6):1481-8. PubMed ID: 23292231
[TBL] [Abstract][Full Text] [Related]
6. Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study.
Khodaie F; Moghadasi AN; Hosseinnataj A; Baghbanian SM; Ashtari F; Razazian N; Poursadeghfard M; Majdi-Nasab N; Hatamian H; Hoseini S; Nahayati MA; Nabavi SM; Faraji F; Harirchian MH; Mir NHN; Moghadam NB; Sharifipour E; Bayati A; Kamali H; Mozhdehipanah H; Jalali N; Abotorabi-Zarchi M; Kamyari N; Nikbakht R; Azimi A; Navardi S; Heidari H; Sahraian MA; Eskandarieh S
Clin Neurol Neurosurg; 2024 Apr; 239():108221. PubMed ID: 38447483
[TBL] [Abstract][Full Text] [Related]
7. Sex ratio of multiple sclerosis and clinical phenotype.
Ramagopalan SV; Byrnes JK; Orton SM; Dyment DA; Guimond C; Yee IM; Ebers GC; Sadovnick AD
Eur J Neurol; 2010 Apr; 17(4):634-7. PubMed ID: 19968710
[TBL] [Abstract][Full Text] [Related]
8. ADC measurements in various patterns of multiple sclerosis lesions.
Phuttharak W; Galassi W; Laopaiboon V; Laopaiboon M; Hesselink JR
J Med Assoc Thai; 2006 Feb; 89(2):196-204. PubMed ID: 16579006
[TBL] [Abstract][Full Text] [Related]
9. Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
Tao C; Simpson S; van der Mei I; Blizzard L; Havrdova E; Horakova D; Shaygannejad V; Lugaresi A; Izquierdo G; Trojano M; Duquette P; Girard M; Grand'Maison F; Grammond P; Alroughani R; Terzi M; Oreja-Guevara C; Sajedi SA; Iuliano G; Sola P; Lechner-Scott J; Pesch VV; Pucci E; Bergamaschi R; Barnett M; Ramo C; Singhal B; LA Spitaleri D; Slee M; Verheul F; Fernández Bolaños R; Amato MP; Cristiano E; Granella F; Hodgkinson S; Fiol M; Gray O; McCombe P; Saladino ML; Sánchez Menoyo JL; Shuey N; Vucic S; Shaw C; Deri N; Arruda WO; Butzkueven H; Spelman T; Taylor BV;
J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1343-1349. PubMed ID: 27810919
[TBL] [Abstract][Full Text] [Related]
10. Increasing incidence of multiple sclerosis in women in Northern Finland.
Krökki O; Bloigu R; Reunanen M; Remes AM
Mult Scler; 2011 Feb; 17(2):133-8. PubMed ID: 20935028
[TBL] [Abstract][Full Text] [Related]
11. Epilepsy in multiple sclerosis: A nationwide population-based register study.
Burman J; Zelano J
Neurology; 2017 Dec; 89(24):2462-2468. PubMed ID: 29117950
[TBL] [Abstract][Full Text] [Related]
12. Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium.
Kister I; Chamot E; Bacon JH; Cutter G; Herbert J;
Mult Scler; 2011 Jun; 17(6):725-33. PubMed ID: 21270059
[TBL] [Abstract][Full Text] [Related]
13. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018.
Moradi N; Sharmin S; Malpas C; Ozakbas S; Shaygannejad V; Terzi M; Boz C; Yamout B; Turkoglu R; Karabudak R; Hamdy S; Soysal A; Altıntaş A; Inshasi J; Al-Harbi T; Alroughani R; Kalincik T;
CNS Drugs; 2021 Oct; 35(10):1097-1106. PubMed ID: 34164782
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.
Sumelahti ML; Tienari PJ; Hakama M; Wikström J
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):25-8. PubMed ID: 12486261
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
[TBL] [Abstract][Full Text] [Related]
16. Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment.
Ouallet JC
Rev Neurol (Paris); 2020 Jun; 176(6):500-504. PubMed ID: 32278541
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
Eur J Neurol; 2014 Nov; 21(11):1353-e88. PubMed ID: 25041631
[TBL] [Abstract][Full Text] [Related]
18. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study.
Orton SM; Ramagopalan SV; Brocklebank D; Herrera BM; Dyment DA; Yee IM; Sadovnick AD; Ebers GC
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):31-6. PubMed ID: 19710047
[TBL] [Abstract][Full Text] [Related]
19. Increasing age at disability milestones among MS patients in the MSBase Registry.
Kister I; Chamot E; Cutter G; Bacon TE; Jokubaitis VG; Hughes SE; Gray OM; Trojano M; Izquierdo G; Grand'Maison F; Duquette P; Lugaresi A; Grammond P; Boz C; Hupperts R; Petersen T; Giuliani G; Oreja-Guevara C; Iuliano G; Lechner-Scott J; Bergamaschi R; Rio ME; Verheul F; Fiol M; Van Pesch V; Slee M; Butzkueven H; Herbert J;
J Neurol Sci; 2012 Jul; 318(1-2):94-9. PubMed ID: 22507751
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of patients with late-onset multiple sclerosis.
Kis B; Rumberg B; Berlit P
J Neurol; 2008 May; 255(5):697-702. PubMed ID: 18283394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
